Retaane News
Most Popular Retaane Story
Alcon faces setback on experimental AMD therapy
Shares of Alcon slipped this morning after the eye care giant announced that the FDA would require another trial of its experimental therapy for wet, age-related macular degeneration. Researchers Read more...
Latest Headlines
- September 25, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
